Market Overview:
The global pets anti-infectives market is expected to grow at a CAGR of 5.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing incidence of zoonotic diseases, rising pet ownership, and growing awareness about pet health and preventive care. In terms of type, the injection segment is expected to lead the global pets anti-infectives market during the forecast period owing to its high efficacy and convenience over other forms such as oral or topical administration. By application, dogs are expected to account for a major share of the global pets anti-infectives market during the forecast period owing to their high susceptibility rates for various infections as compared with cats and other animals. North America is estimated to be leading region in terms of revenue contribution followed by Europe in 2018; however, Asia Pacific is projectedto register highest CAGR overthe forecastperiod duetoincreasing demand from countries such as Chinaand India .
Product Definition:
Pets Anti-infectives are a class of medications that are used to prevent and treat infections in pets. They are important because they can help protect pets from becoming sick and help them recover from infection more quickly.
Injection:
Injection is a medical procedure done by injecting the drug into the body. Injections are most commonly used in humans to treat diseases or to provide nutrition. However, injections can also be used for cosmetic purposes such as Botox (neurotoxin), which is a toxin that reduces wrinkles.
The growth factor for injectables in pets anti-infectives market is driven by factors such as increasing pet population.
Unguent:
Unguent is a topical medication used to treat cuts and abrasions. It helps in the healing process by promoting blood circulation at the site of skin infection. The medication is available in various forms such as ointments, creams, lotions and sprays which are appropriate for different types of infections.
Application Insights:
In 2017, the dogs segment held the largest share of more than 60.0% in terms of revenue. The growth can be attributed to rising pet adoption and increasing spending on anti-infective products for dogs. According to a blog by Statista, there was an increase of around 15% in U.S., Germany, U.K., France and China in dog ownership from 2010 to 2015 respectively which is expected to boost industry growth over the forecast period as well.
The cats segment is expected to grow at a significant rate owing to high product demand due Kittenhood disease which has resulted in increased pet adoption across various regions including North America.
The other application category includes animal care services such as horses or animals kept at home alone such as rabbits or guinea pigs etc.
Regional Analysis:
North America dominated the global pets anti-infectives market in 2017. The rising pet ownership and increasing cases of chronic diseases are some of the major factors responsible for its large share. According to a study published by Global Pet Market Size, Value & Trends Report, U.S., 2018, estimated at USD X billion in 2016 and is expected to grow at a CAGR of XX% from 2017 to 2025 owing to growing consumer awareness regarding pet health along with an increase in spending on veterinary care services over this period.
Asia Pacific is expected to be the fastest-growing region during the forecast period due to high unmet needs related primarily but not exclusively infectious diseases among companion animals particularly dogs.
Growth Factors:
- Increasing demand for pet health products owing to growing awareness about animal health and hygiene.
- Rising prevalence of zoonotic diseases that can be transmitted from animals to humans, which is driving the demand for anti-infectives products for pets.
- Growing trend of pet humanization, where people are increasingly spending on products and services that make their pets feel comfortable and happy, is propelling the growth of the global anti-infectives market for pets.
- Technological advancements in product formulations and increasing R&D investments by manufacturers are resulting in introduction of new and innovative anti-infectives products in the market, which is fuelling market growth.
Scope Of The Report
Report Attributes
Report Details
Report Title
Pets Anti-infectives Market Research Report
By Type
Injection, Unguent
By Application
Dogs, Cats, Other
By Companies
Boehringer Ingelheim, Zoetis, Merck, Elanco, Bayer, Virbac, Ceva Sante Animale, Vetoquinol, Bimeda Animal Health, Chanelle
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
230
Number of Tables & Figures
161
Customization Available
Yes, the report can be customized as per your need.
Global Pets Anti-infectives Market Report Segments:
The global Pets Anti-infectives market is segmented on the basis of:
Types
Injection, Unguent
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Dogs, Cats, Other
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Boehringer Ingelheim
- Zoetis
- Merck
- Elanco
- Bayer
- Virbac
- Ceva Sante Animale
- Vetoquinol
- Bimeda Animal Health
- Chanelle
Highlights of The Pets Anti-infectives Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Injection
- Unguent
- By Application:
- Dogs
- Cats
- Other
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Pets Anti-infectives Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Pets Anti-infectives is a line of pet medications that are designed to help prevent the spread of infection in pets. These medications can be used to treat a variety of infections, including respiratory infections, urinary tract infections, and skin and soft tissue infections.
Some of the major players in the pets anti-infectives market are Boehringer Ingelheim, Zoetis, Merck, Elanco, Bayer, Virbac, Ceva Sante Animale, Vetoquinol, Bimeda Animal Health, Chanelle.
The pets anti-infectives market is expected to grow at a compound annual growth rate of 5.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Pets Anti-infectives Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Pets Anti-infectives Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Pets Anti-infectives Market - Supply Chain
4.5. Global Pets Anti-infectives Market Forecast
4.5.1. Pets Anti-infectives Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Pets Anti-infectives Market Size (000 Units) and Y-o-Y Growth
4.5.3. Pets Anti-infectives Market Absolute $ Opportunity
5. Global Pets Anti-infectives Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Pets Anti-infectives Market Size and Volume Forecast by Type
5.3.1. Injection
5.3.2. Unguent
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Pets Anti-infectives Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Pets Anti-infectives Market Size and Volume Forecast by Application
6.3.1. Dogs
6.3.2. Cats
6.3.3. Other
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Pets Anti-infectives Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Pets Anti-infectives Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Pets Anti-infectives Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Pets Anti-infectives Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Pets Anti-infectives Demand Share Forecast, 2019-2026
9. North America Pets Anti-infectives Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Pets Anti-infectives Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Pets Anti-infectives Market Size and Volume Forecast by Application
9.4.1. Dogs
9.4.2. Cats
9.4.3. Other
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Pets Anti-infectives Market Size and Volume Forecast by Type
9.7.1. Injection
9.7.2. Unguent
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Pets Anti-infectives Demand Share Forecast, 2019-2026
10. Latin America Pets Anti-infectives Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Pets Anti-infectives Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Pets Anti-infectives Market Size and Volume Forecast by Application
10.4.1. Dogs
10.4.2. Cats
10.4.3. Other
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Pets Anti-infectives Market Size and Volume Forecast by Type
10.7.1. Injection
10.7.2. Unguent
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Pets Anti-infectives Demand Share Forecast, 2019-2026
11. Europe Pets Anti-infectives Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Pets Anti-infectives Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Pets Anti-infectives Market Size and Volume Forecast by Application
11.4.1. Dogs
11.4.2. Cats
11.4.3. Other
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Pets Anti-infectives Market Size and Volume Forecast by Type
11.7.1. Injection
11.7.2. Unguent
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Pets Anti-infectives Demand Share, 2019-2026
12. Asia Pacific Pets Anti-infectives Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Pets Anti-infectives Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Pets Anti-infectives Market Size and Volume Forecast by Application
12.4.1. Dogs
12.4.2. Cats
12.4.3. Other
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Pets Anti-infectives Market Size and Volume Forecast by Type
12.7.1. Injection
12.7.2. Unguent
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Pets Anti-infectives Demand Share, 2019-2026
13. Middle East & Africa Pets Anti-infectives Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Pets Anti-infectives Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Pets Anti-infectives Market Size and Volume Forecast by Application
13.4.1. Dogs
13.4.2. Cats
13.4.3. Other
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Pets Anti-infectives Market Size and Volume Forecast by Type
13.7.1. Injection
13.7.2. Unguent
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Pets Anti-infectives Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Pets Anti-infectives Market: Market Share Analysis
14.2. Pets Anti-infectives Distributors and Customers
14.3. Pets Anti-infectives Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Boehringer Ingelheim
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Zoetis
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Merck
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Elanco
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Bayer
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Virbac
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Ceva Sante Animale
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Vetoquinol
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Bimeda Animal Health
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Chanelle
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
